These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 29932767)

  • 21. Radiation-Induced Breast Cancer Incidence and Mortality From Digital Mammography Screening: A Modeling Study.
    Miglioretti DL; Lange J; van den Broek JJ; Lee CI; van Ravesteyn NT; Ritley D; Kerlikowske K; Fenton JJ; Melnikow J; de Koning HJ; Hubbard RA
    Ann Intern Med; 2016 Feb; 164(4):205-14. PubMed ID: 26756460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of mammography screening for breast cancer in a low socioeconomic group of Iranian women.
    Barfar E; Rashidian A; Hosseini H; Nosratnejad S; Barooti E; Zendehdel K
    Arch Iran Med; 2014 Apr; 17(4):241-5. PubMed ID: 24724599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted breast screening could reduce overdiagnosis and be more cost effective, study finds.
    Thornton J
    BMJ; 2018 Jul; 362():k3009. PubMed ID: 29980526
    [No Abstract]   [Full Text] [Related]  

  • 24. Analysis of health benefits and cost-effectiveness of mammography for breast cancer.
    Keen JD
    Ann Intern Med; 2011 Oct; 155(8):566; author reply 566-7. PubMed ID: 22007057
    [No Abstract]   [Full Text] [Related]  

  • 25. Value Analysis of Digital Breast Tomosynthesis for Breast Cancer Screening in a US Medicaid Population.
    Miller JD; Bonafede MM; Herschorn SD; Pohlman SK; Troeger KA; Fajardo LL
    J Am Coll Radiol; 2017 Apr; 14(4):467-474.e5. PubMed ID: 28139412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of mammography, MRI, and ultrasonography for breast cancer screening.
    Feig S
    Radiol Clin North Am; 2010 Sep; 48(5):879-91. PubMed ID: 20868891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.
    Mandelblatt JS; Stout NK; Schechter CB; van den Broek JJ; Miglioretti DL; Krapcho M; Trentham-Dietz A; Munoz D; Lee SJ; Berry DA; van Ravesteyn NT; Alagoz O; Kerlikowske K; Tosteson AN; Near AM; Hoeffken A; Chang Y; Heijnsdijk EA; Chisholm G; Huang X; Huang H; Ergun MA; Gangnon R; Sprague BL; Plevritis S; Feuer E; de Koning HJ; Cronin KA
    Ann Intern Med; 2016 Feb; 164(4):215-25. PubMed ID: 26756606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dutch digital breast cancer screening: implications for breast cancer care.
    Timmers JM; den Heeten GJ; Adang EM; Otten JD; Verbeek AL; Broeders MJ
    Eur J Public Health; 2012 Dec; 22(6):925-9. PubMed ID: 22158996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age to Begin and Intervals for Breast Cancer Screening: Balancing Benefits and Harms.
    Destounis S; Santacroce A
    AJR Am J Roentgenol; 2018 Feb; 210(2):279-284. PubMed ID: 29064754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Program-specific cost-effectiveness analysis: breast cancer screening policies for a safety-net program.
    Melnikow J; Tancredi DJ; Yang Z; Ritley D; Jiang Y; Slee C; Popova S; Rylett P; Knutson K; Smalley S
    Value Health; 2013; 16(6):932-41. PubMed ID: 24041343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overestimation of the Benefit-to-Harm Ratio of Risk-Based Mammography Screening in the United Kingdom-Reply.
    Pashayan N; Pharoah PDP
    JAMA Oncol; 2019 Mar; 5(3):428-429. PubMed ID: 30653219
    [No Abstract]   [Full Text] [Related]  

  • 32. Estimation of the Cost-Effectiveness of Breast Cancer Screening Using Mammography in Mexico Through a Simulation.
    Ulloa-Pérez E; Mohar-Betancourt A; Reynoso-Noverón N
    Rev Invest Clin; 2016; 68(4):184-91. PubMed ID: 27623037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness analysis of mammography screening in Hong Kong Chinese using state-transition Markov modelling.
    Wong IO; Kuntz KM; Cowling BJ; Lam CL; Leung GM
    Hong Kong Med J; 2010 Jun; 16 Suppl 3():38-41. PubMed ID: 20601733
    [No Abstract]   [Full Text] [Related]  

  • 34. Performance goals for an adjunct diagnostic test to reduce unnecessary biopsies after screening mammography: analysis of costs, benefits, and consequences.
    Lee CI; Bensink ME; Berry K; Musa Z; Bodnar C; Dann R; Jarvik JG; Lehman CD; Ramsey SD
    J Am Coll Radiol; 2013 Dec; 10(12):924-30. PubMed ID: 24295942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. To screen or not to screen women in their 40s for breast cancer: is personalized risk-based screening the answer?
    Mandelblatt JS; Stout N; Trentham-Dietz A
    Ann Intern Med; 2011 Jul; 155(1):58-60. PubMed ID: 21727294
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of Breast Cancer Risk Predictive Models and Screening Strategies for Chinese Women.
    Zhao Y; Xiong P; McCullough LE; Miller EE; Li H; Huang Y; Zhao M; Wang MJ; Kang M; Wang Q; Li JY
    J Womens Health (Larchmt); 2017 Mar; 26(3):294-302. PubMed ID: 28263689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Demonstration of Classic Screening Biases, Not Additional Benefit of Annual Over Biennial Screening.
    Barratt A; Bell K; Jacklyn G
    J Am Coll Radiol; 2018 Oct; 15(10):1360. PubMed ID: 30286894
    [No Abstract]   [Full Text] [Related]  

  • 38. Mammography screening: an incremental cost effectiveness analysis of two view versus one view procedures in London.
    Bryan S; Brown J; Warren R
    J Epidemiol Community Health; 1995 Feb; 49(1):70-8. PubMed ID: 7707010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benefits and costs of screening and treatment for early breast cancer. Development of a basic benefit package.
    Kattlove H; Liberati A; Keeler E; Brook RH
    JAMA; 1995 Jan; 273(2):142-8. PubMed ID: 7799495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retrospective observation on contribution and limitations of screening for breast cancer with mammography in Korea: detection rate of breast cancer and incidence rate of interval cancer of the breast.
    Lee K; Kim H; Lee JH; Jeong H; Shin SA; Han T; Seo YL; Yoo Y; Nam SE; Park JH; Park YM
    BMC Womens Health; 2016 Nov; 16(1):72. PubMed ID: 27863517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.